Sio Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Sio Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $3.18 Million - $4.65 Million	40,000 New	40,000 $3.19 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $2.53 Million - $3.22 Million	-29,319 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $3.51 Million - $4.21 Million	-38,152 Reduced 56.55%	29,319 $3.21 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $230,260 - $256,106	2,670 Added 4.12%	67,471 $6.32 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $2.45 Million - $3.26 Million	-34,100 Reduced 34.48%	64,801 $5.96 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $3.26 Million - $4.1 Million	-48,599 Reduced 32.95%	98,901 $7.24 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $8.15 Million - $11.8 Million	147,500 New	147,500 $11.5 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.